Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens.
Bacterial lipoproteins share a common structural motif that has been shown to stimulate proliferation and Ig secretion of murine B cells, in a manner distinct from that mediated by LPSs. Studies of lipoprotein-mediated B cell activation utilized heterogeneous populations of lymphoid cells, leaving unresolved their ability to directly activate resting B cells, as well as their ability to interact with other B cell stimuli. Using highly enriched and/or sort-purified resting murine B cells, we demonstrate that, in contrast to previous reports, lipoproteins (lipoprotein-D, lipoprotein-OspA, and/or the synthetic analogue Pam3Cys) stimulate little, if any, proliferation or Ig secretion in resting B cells. However, when combined with a multivalent membrane (m)Ig-mediated cross-linking signal, dextran-conjugated anti-IgD Abs (alpha delta-dex), lipoproteins mediate up to 10,000-fold inductions in IgM secretion and up to 25-fold enhancements in cellular proliferation relative to that observed with alpha delta-dex alone, in the absence of added cytokines. This mIg-mediated enhancement of Ig secretion was not observed when B cells were stimulated with bivalent, unconjugated anti-Ig. CD40 ligand (CD40L), shows a similar, although somewhat more moderate, synergy with lipoproteins for induction of proliferation and IgM secretion. By contrast, lipoproteins by themselves are relatively ineffective at costimulating Ig secretion in the presence of various combinations of cytokines. These data suggest that bacteria may induce Ag-specific humoral immunity through the action of bacterial polysaccharides that mediate an Ag-specific multivalent mIg signal, in concert with bacterial lipoproteins that deliver ancillary signals, without a requirement for recruitment of non-B cell types.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000942:Antigens, Bacterial / Q000276:immunology*; D000955:Antigens, T-Independent / Q000276:immunology*; D001053:Apolipoproteins / Q000276:immunology*; D053399:Apolipoproteins D; D001402:B-Lymphocytes / Q000187:drug effects*; D023201:CD40 Ligand; D003432:Cross-Linking Reagents / Q000494:pharmacology; D016207:Cytokines / Q000276:immunology; D005260:Female; D008024:Ligands; D008074:Lipoproteins / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008562:Membrane Glycoproteins / Q000276:immunology; D051379:Mice; D008811:Mice, Inbred DBA
D000942:Antigens, Bacterial; D000955:Antigens, T-Independent; D001053:Apolipoproteins; D053399:Apolipoproteins D; D003432:Cross-Linking Reagents; D016207:Cytokines; D008024:Ligands; D008074:Lipoproteins; D008562:Membrane Glycoproteins; C061110:N-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine; D023201:CD40 Ligand